https://www.news-medical.net/news/20231122/Study-finds-among-outpatients-with-mild-to-moderate-COVID-19-treatment-with-fluvoxamine-does-not-reduce-duration-of-symptoms.aspx
0
0
38 words
0
Comments
Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.
You are the first to view
Create an account or login to join the discussion